433 related articles for article (PubMed ID: 9474720)
21. Demineralized bone matrix. Enhancement of spinal fusion.
Frenkel SR; Moskovich R; Spivak J; Zhang ZH; Prewett AB
Spine (Phila Pa 1976); 1993 Sep; 18(12):1634-9. PubMed ID: 8235843
[TBL] [Abstract][Full Text] [Related]
22. In vivo evaluation of demineralized bone matrix as a bone graft substitute for posterior spinal fusion.
Cook SD; Dalton JE; Prewett AB; Whitecloud TS
Spine (Phila Pa 1976); 1995 Apr; 20(8):877-86. PubMed ID: 7644952
[TBL] [Abstract][Full Text] [Related]
23. Experimental spinal fusion using sintered bovine bone coated with type I collagen and recombinant human bone morphogenetic protein-2.
Minamide A; Tamaki T; Kawakami M; Hashizume H; Yoshida M; Sakata R
Spine (Phila Pa 1976); 1999 Sep; 24(18):1863-70; discussion 1871-2. PubMed ID: 10515009
[TBL] [Abstract][Full Text] [Related]
24. 1995 Volvo Award in basic sciences. The use of an osteoinductive growth factor for lumbar spinal fusion. Part II: Study of dose, carrier, and species.
Boden SD; Schimandle JH; Hutton WC
Spine (Phila Pa 1976); 1995 Dec; 20(24):2633-44. PubMed ID: 8747241
[TBL] [Abstract][Full Text] [Related]
25. Antibiotic-loaded bone graft for reduction of surgical site infection in spinal fusion.
Shiels SM; Raut VP; Patterson PB; Barnes BR; Wenke JC
Spine J; 2017 Dec; 17(12):1917-1925. PubMed ID: 28684346
[TBL] [Abstract][Full Text] [Related]
26. Instrumented posterolateral lumbar fusion using coralline hydroxyapatite with or without demineralized bone matrix, as an adjunct to autologous bone.
Thalgott JS; Giuffre JM; Fritts K; Timlin M; Klezl Z
Spine J; 2001; 1(2):131-7. PubMed ID: 14588393
[TBL] [Abstract][Full Text] [Related]
27. Use of a collagen-hydroxyapatite matrix in spinal fusion. A rabbit model.
Tay BK; Le AX; Heilman M; Lotz J; Bradford DS
Spine (Phila Pa 1976); 1998 Nov; 23(21):2276-81. PubMed ID: 9820906
[TBL] [Abstract][Full Text] [Related]
28. 2000 Young Investigator Research Award winner. Evaluation of OP-1 as a graft substitute for intertransverse process lumbar fusion.
Grauer JN; Patel TC; Erulkar JS; Troiano NW; Panjabi MM; Friedlaender GE
Spine (Phila Pa 1976); 2001 Jan; 26(2):127-33. PubMed ID: 11154530
[TBL] [Abstract][Full Text] [Related]
29. Posterolateral lumbar intertransverse process spine arthrodesis with recombinant human bone morphogenetic protein 2/hydroxyapatite-tricalcium phosphate after laminectomy in the nonhuman primate.
Boden SD; Martin GJ; Morone MA; Ugbo JL; Moskovitz PA
Spine (Phila Pa 1976); 1999 Jun; 24(12):1179-85. PubMed ID: 10382242
[TBL] [Abstract][Full Text] [Related]
30. Influence of 45S5 Bioactive Glass in A Standard Calcium Phosphate Collagen Bone Graft Substitute on the Posterolateral Fusion of Rabbit Spine.
Pugely AJ; Petersen EB; DeVries-Watson N; Fredericks DC
Iowa Orthop J; 2017; 37():193-198. PubMed ID: 28852357
[TBL] [Abstract][Full Text] [Related]
31. The use of cultured bone marrow cells in type I collagen gel and porous hydroxyapatite for posterolateral lumbar spine fusion.
Minamide A; Yoshida M; Kawakami M; Yamasaki S; Kojima H; Hashizume H; Boden SD
Spine (Phila Pa 1976); 2005 May; 30(10):1134-8. PubMed ID: 15897826
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of a novel silicate substituted hydroxyapatite bone graft substitute in a rabbit posterolateral fusion model.
Fredericks DC; Petersen EB; Sahai N; Corley KG; DeVries N; Grosland NM; Smucker JD
Iowa Orthop J; 2013; 33():25-32. PubMed ID: 24027457
[TBL] [Abstract][Full Text] [Related]
33. Purified bovine BMP extract and collagen for spine arthrodesis: preclinical safety and efficacy.
Damien CJ; Grob D; Boden SD; Benedict JJ
Spine (Phila Pa 1976); 2002 Aug; 27(16 Suppl 1):S50-8. PubMed ID: 12205421
[TBL] [Abstract][Full Text] [Related]
34. rhBMP-2 enhancement of posterolateral spinal fusion in a rabbit model in the presence of concurrently administered doxorubicin.
Singh K; Smucker JD; Ugbo JL; Tortolani PJ; Tsai L; Fei Q; Kuh S; Rumi M; Heller JG; Boden SD; Yoon ST
Spine J; 2007; 7(3):326-31. PubMed ID: 17482116
[TBL] [Abstract][Full Text] [Related]
35. In vivo evaluation of bone marrow stromal-derived osteoblasts-porous calcium phosphate ceramic composites as bone graft substitute for lumbar intervertebral spinal fusion.
Kai T; Shao-qing G; Geng-ting D
Spine (Phila Pa 1976); 2003 Aug; 28(15):1653-8. PubMed ID: 12897487
[TBL] [Abstract][Full Text] [Related]
36. Posterolateral lumbar spine fusion using a novel demineralized bone matrix: a controlled case pilot study.
Schizas C; Triantafyllopoulos D; Kosmopoulos V; Tzinieris N; Stafylas K
Arch Orthop Trauma Surg; 2008 Jun; 128(6):621-5. PubMed ID: 17978826
[TBL] [Abstract][Full Text] [Related]
37. An experimental lumbar intertransverse process spinal fusion model. Radiographic, histologic, and biomechanical healing characteristics.
Boden SD; Schimandle JH; Hutton WC
Spine (Phila Pa 1976); 1995 Feb; 20(4):412-20. PubMed ID: 7747224
[TBL] [Abstract][Full Text] [Related]
38. In vivo evaluation of a resorbable osteoinductive composite as a graft substitute for lumbar spinal fusion.
Boden SD; Schimandle JH; Hutton WC; Damien CJ; Benedict JJ; Baranowski C; Collier S
J Spinal Disord; 1997 Feb; 10(1):1-11. PubMed ID: 9041490
[TBL] [Abstract][Full Text] [Related]
39. The use of simvastatin in rabbit posterolateral lumbar intertransverse process spine fusion.
Yee AJ; Bae HW; Friess D; Roth SM; Whyne C; Robbin M; Johnstone B; Yoo JU
Spine J; 2006; 6(4):391-6. PubMed ID: 16825044
[TBL] [Abstract][Full Text] [Related]
40. Assessment of MASTERGRAFT PUTTY as a graft extender in a rabbit posterolateral fusion model.
Smucker JD; Petersen EB; Fredericks DC
Spine (Phila Pa 1976); 2012 May; 37(12):1017-21. PubMed ID: 22166929
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
